STOCK TITAN

Onconova Therapeutics Inc - ONTX STOCK NEWS

Welcome to our dedicated news page for Onconova Therapeutics (Ticker: ONTX), a resource for investors and traders seeking the latest updates and insights on Onconova Therapeutics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Onconova Therapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Onconova Therapeutics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.34%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.93%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-66.34%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.72%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.54%
Tags
earnings
Onconova Therapeutics Inc

Nasdaq:ONTX

ONTX Rankings

ONTX Stock Data

20.37M
20.84M
0.78%
7.95%
0.24%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Newtown

About ONTX

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. onconova has three product candidates in clinical trials and six active pre-clinical programs. onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.